Skip to main content
SpringerLink
Log in
Book cover

Psychotropic Agents

Part III: Alcohol and Psychotomimetics, Psychotropic Effects of Central Acting Drugs

  • Book
  • © 1982

Overview

Editors:
  1. F. Hoffmeister

    1. Institut für Pharmakologie, Bayer AG, Wuppertal 1, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. G. Stille

    1. Institut für Arzneimittel des Bundesgesundheitsamtes, Berlin 30, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 55 / 3)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (19 chapters)

  1. Front Matter

    Pages I-XXVI
    Download chapter PDF

  2. Psychotomimetics

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. Chemistry of Psychotomimetics

      • A. T. Shulgin
      Pages 3-29

    3. Pharmacology and Toxicology of Psychotomimetics

      • L. E. Hollister
      Pages 31-44

    4. Psychotomimetics: Behavioral Pharmacology

      • J. B. Appel, A. D. Poling, D. M. Kuhn
      Pages 45-55

    5. Biochemical Pharmacology of Psychotomimetics

      • D. X. Freedman, W. O. Boggan
      Pages 57-88

    6. Neurophysiologic Properties of Psychotomimetics

      • G. K. Aghajanian
      Pages 89-109

    7. Dependence-Producing Liability of LSD and Similar Psychotomimetics

      • A. D. Poling, J. B. Appel
      Pages 111-116

  3. Cannabis

    1. Front Matter

      Pages 117-117
      Download chapter PDF

    2. Chemistry of Cannabis

      • R. Mechoulam
      Pages 119-134

    3. Pharmacology and Toxicology of Cannabis

      • H. Coper
      Pages 135-158

  4. Alcohol

    1. Front Matter

      Pages 159-159
      Download chapter PDF

    2. General Pharmacology and Toxicology of Alcohol

      • T. L. Chruściel
      Pages 161-176

    3. Behavioral Pharmacology of Alcohol

      • N. K. Mello
      Pages 177-208

    4. Biochemical Pharmacology of Alcohol

      • J. Ellingboe, J. H. Mendelson
      Pages 209-237

    5. Dependence-Producing Effects and Alcohol Dependence Syndrome

      • T. L. Chruściel
      Pages 239-265

  5. Psychotropic Effects of Central Acting Drugs

    1. Front Matter

      Pages 267-267
      Download chapter PDF

    2. Psychotropic Effects of Opioids and Opioid Antagonists

      • S. R. Goldberg, R. D. Spealman, H. E. Shannon
      Pages 269-304

    3. Hypnotics

      • W. R. Martin
      Pages 305-329

    4. Anticholinergics

      • L. G. Abood
      Pages 331-347
Back to top

Keywords

About this book

The description of the pharmacology of psychotomimetics, cannabis, and alcohol in this third volume concludes the discussion on psychotropic agents. As psychomotor stimulants these groups of psychotropic agents are of little or no therapeutic relevance, but since they are used in a nonmedical manner, or are even considered by some groups of the population as social commodities, their behavioral effects and psychopharmacological properties are not the concern of the pharmacol­ ogist alone. The same is true of psychotomimetics, as well as cannabis and its components. Psychotomimetics have a social history going back many hundreds of years and are among the most potent psychotropic agents known to man. The closing description of psychopharmacology also deals with the psychotropic effects of a number of drugs not primarily considered to be psychotropic. Their psychotropic effects are either an inherent constituent of their therapeutic profile, as is the case with opiates, hypnotics, and caffeine, or they may occur indirectly as side effects or accompanying effects during therapy. This applies to p-adrenoreceptor antagonists and anticholinergics. The editors are also aware that a description of psychotropic agents would not have been complete without discussing the medical, ethical, and legal aspects of the development, clinical testing, and use of such drugs.

Editors and Affiliations

  • Institut für Pharmakologie, Bayer AG, Wuppertal 1, Germany

    F. Hoffmeister

  • Institut für Arzneimittel des Bundesgesundheitsamtes, Berlin 30, Germany

    G. Stille

Bibliographic Information

  • Book Title: Psychotropic Agents

  • Book Subtitle: Part III: Alcohol and Psychotomimetics, Psychotropic Effects of Central Acting Drugs

  • Editors: F. Hoffmeister, G. Stille

  • Series Title: Handbook of Experimental Pharmacology

  • DOI: https://doi.org/10.1007/978-3-642-67770-0

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 1982

  • Softcover ISBN: 978-3-642-67772-4Published: 15 November 2011

  • eBook ISBN: 978-3-642-67770-0Published: 06 December 2012

  • Series ISSN: 0171-2004

  • Series E-ISSN: 1865-0325

  • Edition Number: 1

  • Number of Pages: XXVI, 508

  • Topics: Pharmacology/Toxicology, Pharmacy

Publish with us

Policies and ethics

Back to top

Search

Navigation